PMWC 2026

Looking forward to sharing what we’ve been building. At PMWC 2026, our Founder and CEO Lalin Theverapperuma, PhD will present Limited Sample Model (LSM), a new AI architecture designed for regulated, data-scarce environments where accuracy, governance, and auditability define performance.

Large foundational models are powerful, but in pharma and clinical workflows, scale alone does not solve the hardest problems. Validation, traceability, and defensible decisions matter.

“Limited Sample Models for Faster Lead Discovery, High Accuracy, and Regulatory Grade AI”

25th Annual Precision Medicine World Conference
Santa Clara Convention Center
Track 2: AI in Drug Discovery & Computational Biology
March 6 | 2:30 PM

If you are evaluating AI for regulated scientific environments, visit us at Booth B605

See LSM in action before Lalin’s session. Explore how governed, sparse-data AI fits into real lab infrastructure.